Close-Up Intl has partnered with AGEPHA Pharma to implement its advanced AI-powered CRM technology, enhancing the pharmaceutical company's sales force capabilities.
Close-Up Intl, a prominent provider of AI-driven customer relationship management (CRM) solutions for the pharmaceutical sector, has recently formed a strategic alliance with AGEPHA Pharma. This partnership involves the deployment of Close-Up’s innovative CRM platform within AGEPHA’s U.S. sales team. The platform is designed to provide real-time insights into healthcare professionals (HCPs), facilitate digital engagement, and optimize sales performance through advanced analytics.
AGEPHA Pharma, recognized for its commitment to addressing unmet medical needs, is particularly focused on cardiovascular treatments, including its FDA-approved product LODOCO® (colchicine). The integration of Close-Up’s CRM technology aims to bolster AGEPHA’s operational efficiency, enabling its sales personnel to better identify market opportunities and enhance customer support.
According to AGEPHA’s Managing Director, the user-friendly interface of the Close-Up CRM allows field personnel to navigate complex data intuitively, which is crucial in a competitive market. This collaboration is expected to not only improve productivity but also drive revenue growth for AGEPHA Pharma as it continues to advance its therapeutic offerings in the U.S.
This partnership underscores the growing importance of AI and data analytics in the pharmaceutical industry, particularly in enhancing sales force effectiveness. As companies like AGEPHA Pharma leverage such technologies, they can better meet the demands of healthcare providers and ultimately improve patient outcomes.